IOVA logo

Iovance Biotherapeutics (IOVA) Company Overview

Profile

Full Name:

Iovance Biotherapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 15, 2010

Indexes:

Not included

Description:

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing products for cancer immunotherapy using the patient's own immune system to destroy cancer cells. The company utilizes its own manufacturing process for tumor therapy, which has reduced manufacturing time from 5-6 weeks to 22 days. In addition, Iovance Biotherapeutics is conducting a number of trials for the treatment of metastatic melanoma, cervical cancer, head and neck cancer, lung cancer, and other forms of cancer. Iovance Biotherapeutics, Inc. was founded in 2007 and is headquartered in San Carlos, California.

Key Details

Price

$4.05

Annual Revenue

$164.07 M(+13698.99% YoY)

Annual EPS

-$1.28(+32.28% YoY)

Annual ROE

-57.48%

Beta

1.76

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 26, 2013

Analyst ratings

Recent major analysts updates

Feb 28, 25 Piper Sandler
Neutral
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Baird
Outperform
Jan 31, 25 Piper Sandler
Neutral
Nov 6, 24 HC Wainwright & Co.
Buy
Oct 24, 24 UBS
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Jul 29, 24 Piper Sandler
Neutral
Jun 28, 24 HC Wainwright & Co.
Buy
Jun 20, 24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Iovance Biotherapeutics?
  • Does Iovance Biotherapeutics pay dividends?
  • What sector is Iovance Biotherapeutics in?
  • What industry is Iovance Biotherapeutics in?
  • What country is Iovance Biotherapeutics based in?
  • When did Iovance Biotherapeutics go public?
  • Is Iovance Biotherapeutics in the S&P 500?
  • Is Iovance Biotherapeutics in the NASDAQ 100?
  • Is Iovance Biotherapeutics in the Dow Jones?
  • When was Iovance Biotherapeutics's last earnings report?
  • When does Iovance Biotherapeutics report earnings?
  • Should I buy Iovance Biotherapeutics stock now?

What is the ticker symbol for Iovance Biotherapeutics?

The ticker symbol for Iovance Biotherapeutics is NASDAQ:IOVA

Does Iovance Biotherapeutics pay dividends?

No, Iovance Biotherapeutics does not pay dividends

What sector is Iovance Biotherapeutics in?

Iovance Biotherapeutics is in the Healthcare sector

What industry is Iovance Biotherapeutics in?

Iovance Biotherapeutics is in the Biotechnology industry

What country is Iovance Biotherapeutics based in?

Iovance Biotherapeutics is headquartered in United States

When did Iovance Biotherapeutics go public?

Iovance Biotherapeutics's initial public offering (IPO) was on October 15, 2010

Is Iovance Biotherapeutics in the S&P 500?

No, Iovance Biotherapeutics is not included in the S&P 500 index

Is Iovance Biotherapeutics in the NASDAQ 100?

No, Iovance Biotherapeutics is not included in the NASDAQ 100 index

Is Iovance Biotherapeutics in the Dow Jones?

No, Iovance Biotherapeutics is not included in the Dow Jones index

When was Iovance Biotherapeutics's last earnings report?

Iovance Biotherapeutics's most recent earnings report was on Feb 27, 2025

When does Iovance Biotherapeutics report earnings?

The date for Iovance Biotherapeutics's next earnings report has not been announced yet

Should I buy Iovance Biotherapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions